Incyte claims EU approval for Zynyz as the first systemic therapy for anal cancer, as J&J gets the nod for wider use of Akeega in prostate cancer.
Hope rises for vaccine against hookworm parasite
Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.


